Continuous and bimonthly publication
ISSN (on-line): 1806-3756

Licença Creative Commons
8009
Views
Back to summary
Open Access Peer-Reviewed
Artigo Original

Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

Diferentes modelos para avaliar a relação custo-efetividade de inibidores de tirosina quinase do EGFR no tratamento do câncer de pulmão não pequenas células metastático no contexto do Sistema Único de Saúde

Pedro Aguiar Jr1, Felipe Roitberg2, Gilberto Lopes Jr3, Auro del Giglio4


Message

 

 

This article not yet has been commented, be the first!

 


Indexes

Development by:

© All rights reserved 2024 - Jornal Brasileiro de Pneumologia